NPY and cancer: No significant differences between expression of NPY and its receptors in control BP cases and cancer-free prostate tissue from PCa cohort were found (NPY p = 0.60, Y1R, p = 0.86, Y2R p = 0.79, Y5R p = 0.26); therefore, all of them constituted the BP group.